US Stock MarketDetailed Quotes

CTXR Citius Pharmaceuticals

Watchlist

0.5362
+0.0062+1.17%

Trading Sep 9 15:03 ET

96.90MMarket Cap-2234P/E (TTM)

Citius Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Jun 30, 2024

(Q2)Mar 31, 2024

(Q1)Dec 31, 2023

(FY)Sep 30, 2023

(Q4)Sep 30, 2023

(Q3)Jun 30, 2023

(Q2)Mar 31, 2023

(Q1)Dec 31, 2022

(FY)Sep 30, 2022

(Q4)Sep 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

22.63%10.63M

2.67%10.97M

28.84%9.34M

10.25%36.73M

34.11%10.12M

-2.74%8.67M

40.77%10.69M

-21.70%7.25M

41.58%33.32M

45.09%7.55M

Selling and administrative expenses

60.38%7.87M

23.59%7.36M

76.61%6.72M

39.92%21.91M

96.14%7.24M

21.82%4.91M

43.98%5.96M

0.08%3.8M

38.69%15.66M

26.93%3.69M

-General and administrative expense

60.38%7.87M

23.59%7.36M

76.61%6.72M

39.92%21.91M

96.14%7.24M

21.82%4.91M

43.98%5.96M

0.08%3.8M

38.69%15.66M

26.93%3.69M

Research and development costs

-26.58%2.76M

-23.71%3.61M

-23.90%2.62M

-16.06%14.82M

-25.27%2.88M

-22.98%3.76M

36.92%4.73M

-36.87%3.45M

44.24%17.66M

68.13%3.86M

Operating profit

-22.63%-10.63M

-2.67%-10.97M

-28.84%-9.34M

-10.25%-36.73M

-34.11%-10.12M

2.74%-8.67M

-40.77%-10.69M

21.70%-7.25M

-41.58%-33.32M

-45.09%-7.55M

Net non-operating interest income expense

-39.18%204.84K

-39.92%182.21K

18.22%253.64K

369.14%1.18M

140.91%324.81K

535.19%336.78K

925.58%303.28K

531.36%214.55K

0.16%251.4K

78.34%134.83K

Non-operating interest income

-39.18%204.84K

-39.92%182.21K

18.22%253.64K

369.14%1.18M

140.91%324.81K

535.19%336.78K

925.58%303.28K

531.36%214.55K

-3.98%251.4K

78.34%134.83K

Other net income (expense)

2.39M

3.59M

Other non- operating income (expenses)

----

--2.39M

----

--3.59M

--0

----

--3.59M

----

Income before tax

-25.12%-10.43M

19.09%-8.4M

-163.42%-9.09M

3.32%-31.97M

-32.17%-9.8M

5.96%-8.34M

-37.31%-10.38M

62.61%-3.45M

-43.42%-33.06M

-49.46%-7.41M

Income tax

0.00%144K

0.00%576K

-75.00%144K

144K

576K

Net income

-24.70%-10.57M

18.83%-8.54M

-156.88%-9.23M

3.26%-32.54M

-24.44%-9.94M

4.34%-8.48M

-39.21%-10.53M

61.05%-3.59M

-45.92%-33.64M

-61.07%-7.99M

Net income continuous Operations

-24.70%-10.57M

18.83%-8.54M

-156.88%-9.23M

3.26%-32.54M

-24.44%-9.94M

4.34%-8.48M

-39.21%-10.53M

61.05%-3.59M

-45.92%-33.64M

-61.07%-7.99M

Minority interest income

Net income attributable to the parent company

-24.70%-10.57M

18.83%-8.54M

-156.88%-9.23M

3.26%-32.54M

-24.44%-9.94M

4.34%-8.48M

-39.21%-10.53M

61.05%-3.59M

-45.92%-33.64M

-61.07%-7.99M

Preferred stock dividends

Other preferred stock dividends

321.56K

1.15M

Net income attributable to common stockholders

-28.49%-10.89M

18.83%-8.54M

-156.88%-9.23M

-0.16%-33.69M

-38.85%-11.1M

4.34%-8.48M

-39.21%-10.53M

61.05%-3.59M

-37.28%-33.64M

-61.07%-7.99M

Basic earnings per share

0.00%-0.06

28.57%-0.05

-200.00%-0.06

4.35%-0.22

-40.00%-0.07

0.00%-0.06

-40.00%-0.07

66.67%-0.02

0.00%-0.23

-66.67%-0.05

Diluted earnings per share

0.00%-0.06

28.57%-0.05

-200.00%-0.06

4.35%-0.22

-40.00%-0.07

0.00%-0.06

-40.00%-0.07

66.67%-0.02

0.00%-0.23

-66.67%-0.05

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q3)Jun 30, 2024	(Q2)Mar 31, 2024	(Q1)Dec 31, 2023	(FY)Sep 30, 2023	(Q4)Sep 30, 2023	(Q3)Jun 30, 2023	(Q2)Mar 31, 2023	(Q1)Dec 31, 2022	(FY)Sep 30, 2022	(Q4)Sep 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	22.63%10.63M	2.67%10.97M	28.84%9.34M	10.25%36.73M	34.11%10.12M	-2.74%8.67M	40.77%10.69M	-21.70%7.25M	41.58%33.32M	45.09%7.55M
Selling and administrative expenses	60.38%7.87M	23.59%7.36M	76.61%6.72M	39.92%21.91M	96.14%7.24M	21.82%4.91M	43.98%5.96M	0.08%3.8M	38.69%15.66M	26.93%3.69M
-General and administrative expense	60.38%7.87M	23.59%7.36M	76.61%6.72M	39.92%21.91M	96.14%7.24M	21.82%4.91M	43.98%5.96M	0.08%3.8M	38.69%15.66M	26.93%3.69M
Research and development costs	-26.58%2.76M	-23.71%3.61M	-23.90%2.62M	-16.06%14.82M	-25.27%2.88M	-22.98%3.76M	36.92%4.73M	-36.87%3.45M	44.24%17.66M	68.13%3.86M
Operating profit	-22.63%-10.63M	-2.67%-10.97M	-28.84%-9.34M	-10.25%-36.73M	-34.11%-10.12M	2.74%-8.67M	-40.77%-10.69M	21.70%-7.25M	-41.58%-33.32M	-45.09%-7.55M
Net non-operating interest income expense	-39.18%204.84K	-39.92%182.21K	18.22%253.64K	369.14%1.18M	140.91%324.81K	535.19%336.78K	925.58%303.28K	531.36%214.55K	0.16%251.4K	78.34%134.83K
Non-operating interest income	-39.18%204.84K	-39.92%182.21K	18.22%253.64K	369.14%1.18M	140.91%324.81K	535.19%336.78K	925.58%303.28K	531.36%214.55K	-3.98%251.4K	78.34%134.83K
Other net income (expense)		2.39M		3.59M	0			3.59M
Other non- operating income (expenses)	----	--2.39M	----	--3.59M	--0	----	----	--3.59M	----	----
Income before tax	-25.12%-10.43M	19.09%-8.4M	-163.42%-9.09M	3.32%-31.97M	-32.17%-9.8M	5.96%-8.34M	-37.31%-10.38M	62.61%-3.45M	-43.42%-33.06M	-49.46%-7.41M
Income tax	0.00%144K	0.00%144K	0.00%144K	0.00%576K	-75.00%144K	144K	144K	144K	576K	576K
Net income	-24.70%-10.57M	18.83%-8.54M	-156.88%-9.23M	3.26%-32.54M	-24.44%-9.94M	4.34%-8.48M	-39.21%-10.53M	61.05%-3.59M	-45.92%-33.64M	-61.07%-7.99M
Net income continuous Operations	-24.70%-10.57M	18.83%-8.54M	-156.88%-9.23M	3.26%-32.54M	-24.44%-9.94M	4.34%-8.48M	-39.21%-10.53M	61.05%-3.59M	-45.92%-33.64M	-61.07%-7.99M
Minority interest income
Net income attributable to the parent company	-24.70%-10.57M	18.83%-8.54M	-156.88%-9.23M	3.26%-32.54M	-24.44%-9.94M	4.34%-8.48M	-39.21%-10.53M	61.05%-3.59M	-45.92%-33.64M	-61.07%-7.99M
Preferred stock dividends
Other preferred stock dividends	321.56K			1.15M	1.15M	0			0
Net income attributable to common stockholders	-28.49%-10.89M	18.83%-8.54M	-156.88%-9.23M	-0.16%-33.69M	-38.85%-11.1M	4.34%-8.48M	-39.21%-10.53M	61.05%-3.59M	-37.28%-33.64M	-61.07%-7.99M
Basic earnings per share	0.00%-0.06	28.57%-0.05	-200.00%-0.06	4.35%-0.22	-40.00%-0.07	0.00%-0.06	-40.00%-0.07	66.67%-0.02	0.00%-0.23	-66.67%-0.05
Diluted earnings per share	0.00%-0.06	28.57%-0.05	-200.00%-0.06	4.35%-0.22	-40.00%-0.07	0.00%-0.06	-40.00%-0.07	66.67%-0.02	0.00%-0.23	-66.67%-0.05
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall